PTHS · Pelthos Therapeutics Inc. · Share Buybacks
$20.35
-0.66 (-3.14%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“in prior periods, management disclosed substantial doubt about the Company's ability to continue as a going concern. The conditions and events that previously raised substantial doubt have been alleviated by management's plans and actions.”View the 10-Q filed May 14, 2026
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 1
44.59K
Avg daily vol (3M)
58.25K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1,250,000
as of 2024-10-22
· total across 2 concurrent programs
Concurrent Repurchase Programs
| Authorized | As of | Remaining | Remaining as of | Source |
|---|---|---|---|---|
| $500,000 | 2024-10-22 | — | — | 10-Q, filed 2025-08-13 |
| $750,000 | 2024-10-22 | — | — | 10-Q, filed 2025-08-13 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-19 |
| 2024-12-31 | $75,000 | 10-K, filed 2026-03-19 |